These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24112773)

  • 21. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
    Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
    Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognostic eight-lncRNA expression signature in predicting recurrence of ER-positive breast cancer receiving endocrine therapy.
    Tang J; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
    J Cell Physiol; 2020 May; 235(5):4746-4755. PubMed ID: 31663114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of efficacy of 95-gene and 21-gene classifier (Oncotype DX) for prediction of recurrence in ER-positive and node-negative breast cancer patients.
    Naoi Y; Kishi K; Tsunashima R; Shimazu K; Shimomura A; Maruyama N; Shimoda M; Kagara N; Baba Y; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2013 Jul; 140(2):299-306. PubMed ID: 23884597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer genomics predicts disease relapse and therapeutic response to neoadjuvant chemotherapy of hormone sensitive breast cancers.
    Zhu J; Muskhelishvili L; Tong W; Borlak J; Chen M
    Sci Rep; 2020 May; 10(1):8188. PubMed ID: 32424219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiple breast cancer stem cell model to predict recurrence of T
    Qiu Y; Wang L; Zhong X; Li L; Chen F; Xiao L; Liu F; Fu B; Zheng H; Ye F; Bu H
    BMC Cancer; 2019 Jul; 19(1):729. PubMed ID: 31340763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 16 Yin Yang gene expression ratio signature for ER+/node- breast cancer.
    Xu W; Jia G; Cai N; Huang S; Davie JR; Pitz M; Banerji S; Murphy L
    Int J Cancer; 2017 Mar; 140(6):1413-1424. PubMed ID: 27925180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genes and functions from breast cancer signatures.
    Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma.
    Zhou JG; Zhong H; Zhang J; Jin SH; Roudi R; Ma H
    Front Oncol; 2019; 9():78. PubMed ID: 30828567
    [No Abstract]   [Full Text] [Related]  

  • 32. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
    Chanrion M; Negre V; Fontaine H; Salvetat N; Bibeau F; Mac Grogan G; Mauriac L; Katsaros D; Molina F; Theillet C; Darbon JM
    Clin Cancer Res; 2008 Mar; 14(6):1744-52. PubMed ID: 18347175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a robust multigene signature as an aid to predict early relapse in stage I-III clear cell and papillary renal cell cancer.
    Cao DL; Dai WX; Huang YQ; Yu LJ; Wu JL; Shi GH; Zhang HL; Zhu Y; Dai B; Ye DW
    J Cancer; 2020; 11(5):997-1007. PubMed ID: 31956346
    [No Abstract]   [Full Text] [Related]  

  • 34. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.
    Synnestvedt M; Borgen E; Russnes HG; Kumar NT; Schlichting E; Giercksky KE; Kåresen R; Nesland JM; Naume B
    Acta Oncol; 2013 Jan; 52(1):91-101. PubMed ID: 22934555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data.
    Győrffy B; Benke Z; Lánczky A; Balázs B; Szállási Z; Timár J; Schäfer R
    Breast Cancer Res Treat; 2012 Apr; 132(3):1025-34. PubMed ID: 21773767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a novel mRNA signature for predicting early relapse in non-small cell lung cancer.
    Lin J; Weng J; Lin S; Lin C; Huang J; Zhang C; Zhang S; Dong C; Ji H; Ke X
    Jpn J Clin Oncol; 2021 Aug; 51(8):1277-1286. PubMed ID: 34037221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of early breast cancer metastasis from DNA microarray data using high-dimensional cox regression models.
    Zemmour C; Bertucci F; Finetti P; Chetrit B; Birnbaum D; Filleron T; Boher JM
    Cancer Inform; 2015; 14(Suppl 2):129-38. PubMed ID: 25983547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.